跳至主要内容
临床试验/NL-OMON23015
NL-OMON23015已完成不适用

Randomized Phase 2 study with Gemzar and Cisplatin combination with or without Vitamin Supplementation in patients with advanced Esophagogastric Cancer.

Vu Medical center0 个研究点目标入组 82 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
82

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients must have histologically or cytological confirmed metastatic or locally advanced unresectable advanced esophagogastric carcinoma (squamous or adenocarcinoma), not amenable for curative treatment.
  • 2. Patients may have received prior surgery, and chemotherapy and/or radiotherapy in neo-adjuvant or adjuvant setting as long as the chemotherapy was completed at least 6 months prior to study entry.

排除标准

  • 1. Active infection or cardiac disease, at the investigator’s criteria.
  • 2. Pregnancy or breast-feeding.

研究者

发起方
Vu Medical center

相似试验

Chemotherapy +/- vitamine supplementation in... | 临床试验